Dr. Mechoulam’s latest discovery is called EPM301, or cannabidiolic acid methyl ester, also known as CBDa. EPM stands for Endless Potential Molecules, and there are now around 14 patented molecules that are being tested on humans with the US FDAs guidance. The first targets of EPM are psoriasis and inflammatory bowel disease (IBD), which are notoriously difficult to treat.
Excerpt only …
READ MORE BELOW
Source : Meet EPM301 – Dr. Raphael Mechoulam's Latest Discovery That is More Potent Than THC and CBD
reposted by Cannabis News World